{"id":"https://openalex.org/W2007097981","doi":"https://doi.org/10.1158/1538-7445.am2012-5591","title":"Abstract 5591: A phase I study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma (HCC)","display_name":"Abstract 5591: A phase I study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma (HCC)","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2007097981","doi":"https://doi.org/10.1158/1538-7445.am2012-5591","mag":"2007097981"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-5591","doi":"https://doi.org/10.1158/1538-7445.am2012-5591","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-5591","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085283718","display_name":"Adam Charles Yopp","orcid":"https://orcid.org/0000-0002-5887-5315","observed_orcids":["https://orcid.org/0000-0002-5887-5315"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Yopp","raw_affiliation_strings":["1UT Southwestern Medical Center, Dallas, TX","#N#1UT Southwestern Medical Center, Dallas, TX#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"#N#1UT Southwestern Medical Center, Dallas, TX#N#","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001848409","display_name":"Yull Arriega","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yull Arriega","raw_affiliation_strings":["1UT Southwestern Medical Center, Dallas, TX","#N#1UT Southwestern Medical Center, Dallas, TX#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"#N#1UT Southwestern Medical Center, Dallas, TX#N#","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014214683","display_name":"Amit G. Singal","orcid":"https://orcid.org/0000-0002-1172-3971","observed_orcids":["https://orcid.org/0000-0002-1172-3971"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amit Singal","raw_affiliation_strings":["1UT Southwestern Medical Center, Dallas, TX","#N#1UT Southwestern Medical Center, Dallas, TX#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"#N#1UT Southwestern Medical Center, Dallas, TX#N#","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053019255","display_name":"John C. Mansour","orcid":"https://orcid.org/0000-0001-6346-9429","observed_orcids":["https://orcid.org/0000-0001-6346-9429"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Mansour","raw_affiliation_strings":["1UT Southwestern Medical Center, Dallas, TX","#N#1UT Southwestern Medical Center, Dallas, TX#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"#N#1UT Southwestern Medical Center, Dallas, TX#N#","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000911653","display_name":"Glen C. Balch","orcid":"https://orcid.org/0000-0002-1575-9170","observed_orcids":["https://orcid.org/0000-0002-1575-9170"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glen Balch","raw_affiliation_strings":["1UT Southwestern Medical Center, Dallas, TX","#N#1UT Southwestern Medical Center, Dallas, TX#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"#N#1UT Southwestern Medical Center, Dallas, TX#N#","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042527153","display_name":"Phillip Thorpe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phillip Thorpe","raw_affiliation_strings":["1UT Southwestern Medical Center, Dallas, TX","#N#1UT Southwestern Medical Center, Dallas, TX#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"#N#1UT Southwestern Medical Center, Dallas, TX#N#","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I867280407"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"5591","last_page":"5591"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bavituximab","display_name":"bavituximab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.8790000081062317},{"id":"https://openalex.org/keywords/advanced-liver-cancer","display_name":"advanced liver cancer","score":0.6710000038146973},{"id":"https://openalex.org/keywords/phosphatidylserine","display_name":"phosphatidylserine","score":0.8360000252723694},{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.609000027179718},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7829999923706055},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8500000238418579},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6299999952316284},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.7760000228881836},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6840000152587891},{"id":"https://openalex.org/keywords/liver-cirrhosis","display_name":"liver cirrhosis","score":0.7440000176429749},{"id":"https://openalex.org/keywords/immune-reactivation","display_name":"immune reactivation","score":0.527999997138977},{"id":"https://openalex.org/keywords/metastatic-disease","display_name":"metastatic disease","score":0.5730000138282776},{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.382999986410141},{"id":"https://openalex.org/keywords/hepatitis-b-virus","display_name":"hepatitis B virus","score":0.968999981880188},{"id":"https://openalex.org/keywords/nash","display_name":"NASH","score":0.8339999914169312}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9650816917419434},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9002734422683716},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.8634916543960571},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6689683198928833},{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.574026346206665},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5507282018661499},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48808753490448},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47999972105026245},{"id":"https://openalex.org/C2776231280","wikidata":"https://www.wikidata.org/wiki/Q623031","display_name":"Liver cancer","level":3,"score":0.4369598925113678},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4167577028274536}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-5591","doi":"https://doi.org/10.1158/1538-7445.am2012-5591","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-5591","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4229485830","https://openalex.org/W2243707214","https://openalex.org/W2969756092","https://openalex.org/W2323600409","https://openalex.org/W2068890762","https://openalex.org/W2259721887","https://openalex.org/W2024398897","https://openalex.org/W2002741555","https://openalex.org/W2267848039","https://openalex.org/W2621190609"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"HCC":[2,52,77,295],"is":[3,43],"the":[4,12,15,27,37,91,107,249,311,350,355],"fastest":[5],"growing":[6],"cause":[7],"of":[8,17,101,112,120,156,175,200,231,349,354],"cancer-related":[9],"deaths":[10],"in":[11,34,50,68,75,114,122,248,291,332,338],"US,":[13],"with":[14,20,31,70,116,124,139,293,319,323],"majority":[16,199],"patients":[18,42,123,138,176,183,187,193,201,216,225,292],"presenting":[19],"advanced":[21,35,125,141,294],"stage":[22],"disease.":[23],"Despite":[24],"sorafenib":[25,71,121,165,263,286,324],"being":[26,330],"only":[28],"systemic":[29],"therapy":[30,81],"proven":[32],"efficacy":[33,74],"HCC,":[36,142],"median":[38],"survival":[39],"for":[40,169,358],"these":[41],"still":[44],"less":[45],"than":[46,79],"one":[47,206,211],"year.":[48],"Sorafenib,":[49],"pre-clinical":[51,76],"models,":[53],"upregulates":[54],"phosphatidylserine":[55,63],"(PS)":[56],"exposure":[57],"on":[58],"tumor":[59,93,98],"vascular":[60],"endothelium.":[61],"The":[62,198],"(PS)-targeting":[64],"antibody,":[65],"bavituximab,":[66],"given":[67,289],"combination":[69,115],"has":[72],"greater":[73],"models":[78],"either":[80],"alone.":[82],"Bavituximab":[83,284],"acts":[84],"by":[85,96],"directing":[86],"immune":[87],"cells":[88],"to":[89,105,262],"destroy":[90],"PS-expressing":[92],"vasculature,":[94],"and":[95,147,161,164,181,191,210,264,278,285,300,308,316],"reactivating":[97],"immunity.The":[99],"aim":[100],"our":[102],"study":[103,134,337],"was":[104,177],"evaluate":[106],"maximum":[108],"tolerated":[109],"dose":[110,234,241],"(MTD)":[111],"bavituximab":[113,157],"400":[117,166,301],"mg":[118,167,302],"bid":[119,168],"HCC.":[126],"Methods:":[127],"In":[128],"this":[129,339],"single":[130],"institution,":[131],"phase":[132,335],"I":[133],"(NCT01264705),":[135],"sorafenib-naive":[136],"adult":[137],"measurable,":[140],"ECOG":[143],"PS":[144],"\u2264":[145],"2,":[146],"Child-Pugh":[148],"(CP)":[149],"class":[150],"A":[151],"cirrhosis":[152],"received":[153,221],"escalating":[154],"doses":[155,327],"weekly":[158,299],"(0.3,":[159],"1.0,":[160],"3.0":[162,297],"mg/kg)":[163],"28":[170,251],"days.":[171],"Results:":[172],"Median":[173],"age":[174],"61(range":[178],"43-76)":[179],"years":[180],"seven":[182],"were":[184,237,253,260,310],"male.":[185],"Five":[186,215],"had":[188,194,202,208,213,226],"CP":[189,195],"A5":[190],"4":[192],"A6":[196],"cirrhosis.":[197],"underlying":[203],"HCV":[204],"(7/9),":[205],"patient":[207,212],"HBV":[209],"NASH.":[214],"(4":[217],"TACE,":[218],"1":[219],"resection)":[220],"prior":[222],"treatment.":[223,232],"Four":[224],"metastatic":[227],"disease":[228],"at":[229,239,257,296],"initiation":[230],"No":[233,243],"limiting":[235],"toxicities":[236,256],"seen":[238],"any":[240],"level.":[242],"grade":[244,269,272,276,281],"3/4":[245],"treatment-related":[246],"events":[247,315,322],"first":[250],"days":[252],"noted.":[254],"Common":[255],"all":[258],"grades":[259],"related":[261],"included":[265],"hand-foot":[266],"syndrome":[267],"(33%":[268,275],"I,":[270],"22%":[271],"II),":[273],"fatigue":[274,307],"I)":[277],"anorexia":[279,309],"(22%":[280],"I).":[282],"Conclusions:":[283],"can":[287],"be":[288],"safely":[290],"mg/kg":[298],"bid,":[303],"respectively.":[304],"Hand-foot":[305],"syndrome,":[306],"most":[312],"common":[313],"adverse":[314,321],"are":[317,328],"consistent":[318],"known":[320],"therapy.":[325],"These":[326],"currently":[329],"evaluated":[331],"an":[333],"ongoing":[334],"II":[336],"population.":[340],"Citation":[341],"Format:":[342],"{Authors}.":[343],"{Abstract":[344],"title}":[345],"[abstract].":[346],"In:":[347],"Proceedings":[348],"103rd":[351],"Annual":[352],"Meeting":[353],"American":[356],"Association":[357],"Cancer":[359,370],"Research;":[360],"2012":[361],"Mar":[362],"31-Apr":[363],"4;":[364],"Chicago,":[365],"IL.":[366],"Philadelphia":[367],"(PA):":[368],"AACR;":[369],"Res":[371],"2012;72(8":[372],"Suppl):Abstract":[373],"nr":[374],"5591.":[375],"doi:1538-7445.AM2012-5591":[376]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}